drugset / Trial / NCT00470145

Comparison Of Two Tablet Formulations Of SB-568859

NCT00470145 ↗

Phase 1 Completed 28 enrolled GlaxoSmithKline
RandomizedCrossoverSingle-blindTreatment

Summary

SB-568859 is a medication that is being developed for the treatment of atherosclerosis (hardening of the arteries). The purpose of this study is to see if there is a difference in how the human body takes up the study drug depending on how the study drug is made. This study will compare SB-568859 tablets that are made in 2 different ways. This is not a treatment study.

Timeline

Start
2007-04
Primary completion
—
Completion
2007-07

Drugs

EvaluationDrugModalityDoseRoute
Subject SB-568859 Unknown — —

Indications